Related references
Note: Only part of the references are listed.Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Sherene Loi et al.
BMC GENOMICS (2008)
The helix-loop-helix protein Id1 requires cyclin D1 to promote the proliferation of mammary epithelial cell acini
C. Elizabeth Caldon et al.
CANCER RESEARCH (2008)
Basal-like breast cancer defined by five biomarkers has superior prognostic value then triple-negative phenotype
Maggie C. U. Cheang et al.
CLINICAL CANCER RESEARCH (2008)
Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer
Yasmine Nadler et al.
BREAST CANCER RESEARCH (2008)
Overexpression and gene amplification of BAG-IL in hormone-refractory prostate cancer
H. E. Maki et al.
JOURNAL OF PATHOLOGY (2007)
Progress and promise:: highlights of the international expert consensus on the primary therapy of early breast cancer 2007
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2007)
A gene-expression signature to predict survival in breast cancer across independent data sets
A. Naderi et al.
ONCOGENE (2007)
Do classical oestrogen markers predict for clinical response to endocrine therapy?
William R. Miller
BREAST CANCER RESEARCH (2007)
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
Soonmyung Paik et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index
GM Callagy et al.
CLINICAL CANCER RESEARCH (2006)
A multimarker model to predict outcome in tamoxifen-treated breast cancer patients
SP Linke et al.
CLINICAL CANCER RESEARCH (2006)
Gene expression patterns for doxorubicin (Adriamycin) and cyclophosphamide (Cytoxan) (AC) response and resistance
S Cleator et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling
MPHM Jansen et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
BAG-1 expression correlates with Bcl-2, p53, differentiation, estrogen and progesterone receptors in invasive breast carcinoma
SC Tang et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen
XJ Ma et al.
CANCER CELL (2004)
The nuclear BAG-1 isoform, BAG-1L, enhances oestrogen-dependent transcription
RI Cutress et al.
ONCOGENE (2003)
Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures
J Debnath et al.
METHODS (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
BAG-I expression and function in human cancer
RI Cutress et al.
BRITISH JOURNAL OF CANCER (2002)
BAG-1 expression in human breast cancer: interrelationship between BAG-1 RNA, protein, HSC70 expression and clinico-pathological data
PA Townsend et al.
JOURNAL OF PATHOLOGY (2002)
Bag1 is a regulator and marker of neuronal differentiation
P Kermer et al.
CELL DEATH AND DIFFERENTIATION (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
BAG-1 expression correlates highly with the malignant potential in early lesions (T1 and T2) of oral squamous cell carcinoma
M Shindoh et al.
ORAL ONCOLOGY (2000)
Share Paper
